News About: Pharm. Industry
Regarding delayed report over Olita side effects, Hanmi will do best not to happen again
Regarding the Board of Audit and Inspection’s audit result that it took 14 months for the SJS(Stevens-Johnson syndrome) occurrence to be reported to the Ministry of Food and Drug Safety(MFDS), Hanmi Pharm explained “T...
BAI, “Hanmi truly delayed the report about ‘Olita,’ but no intention was found”
The Hanmi Pharm’s delayed report on the side effect of ‘Olita Tab’ was officially confirmed.
According to audit result on the Hanmi Pharm’s clinical trial for Olita Tab, requested by the National Assembly, the Board ...
Multinational pharmas with increased sales, but decreased profitability
Multinational pharmaceutical companies which branched in Korea recorded 7% higher sales, but decreased operating profits and net profits last year.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of ...
2 of 3 innovative pharmas record operating profit ratio less than 10%
It was observed the innovative pharmaceutical companies’ operating profit ratio was weakened.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 47 innovative pharmaceutical companies’ 2016 audit rep...
KPDS, “Novartis’ illegality is clear… it is time to explain generics’ safety to patients”
The Korean Pharmacists for Democratic Society(KPDS) urged prompt and strict administrative measures for the Novartis Korea’s rebate case.
In the statement on the 12th, the KPDS announced the Ministry of Health and We...
Pharma & Bio-pharma will revitalize with relieved anxiety and devotion to R&D
The pharmaceutical field will revitalize.
The unexpected incident at the end of the last year continued until the beginning of this year, but it seems it is going to be settled soon, which energizes the industry.
It...
CCEJ, “MOHW must suspend health insurance benefits on Novartis’ products”
The Citizens’ Coalition for Economic Justice(CCEJ) has started to call for suspension of health insurance benefits on Novartis’ pharmaceutical products dealt with rebate.
In the statement on the 11th, the CCEJ argued...
Prosecution’s fierce strike on HIRA over pharmas’ provision of rebates
The prosecution has strongly pressured pharmaceutical companies and wholesalers. It has omnidirectionally target all the organization related to rebate.
According to the industry concerned, the Eastern Branch of Busa...
Can’t make orders because of products forcefully pushed in?
While strictly managing regulations related to return and payment for stocked pharmaceutical products, pharmaceutical companies have kept pushing in the products to distribution companies, which has raised a lot of co...
Pharma industry generates 3 mega blockbuster products recording sales more than KRW 100 billion
It was observed 3 mega blockbuster products, which made annual sales more than KRW 100 billion, were launched last year.
Dong-A Pharm’s quasi drug ‘Bacchus’ recorded the largest sales as a single product with KRW 212...
